Celgene Corporation, CELG is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Celgene Corporation, CELG has a market cap of 83246.82. Since its IPO date on the 3/26/1990, Celgene Corporation, CELG performance year to date is -10.32%. Today Celgene Corporation, CELG has gained 1.03%, with a current price of 107.4.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 79.20%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 7.20%, with return on investment at 8.90%.
In terms of debt levels and profit levels, Celgene Corporation, CELG is seeing a long-term debt/equity of 2.58. While Total debt/equity is 0. With a profit margin of 18.90%, this is combined with a gross margin of 95.70%, and operating margin of 27.10%. Celgene Corporation ability to meet debt levels, with a current ratio of 4.6, while the quick ratio is 4.4.
For the last year Celgene Corporation, CELG has seen a EPS growth of -18.80%. A performance for the year of 2.49%. The 52-week high is -16.35%, and the 52-week low is 15.42%. The average volume for Celgene Corporation, CELG is 3265400.
With a target price of 137.3, can Celgene Corporation, CELG reach this target? Looking at the value indicators of Celgene Corporation, CELG. Celgene Corporation has a P/E of 45.09 and a forward P/E of 15.36. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.06. Celgene Corporation also has a P/S and a P/B of 8.19 and 15.02 respectively. For P/cash, Celgene Corporation has a value of 13, while it is 28.13 for P/free cash flow.
At the current price of 107.4, Celgene Corporation has a dividend yield of *TBA. We see a return on equity of 35.10%.
Looking more long-term Celgene Corporation, is projected to get an EPS growth for the next five years of 21.87%. In the short-term an EPS growth of 22.53% in the next year is forecasted. This is after a EPS growth of -18.80% for this year and for the last five years a 15.70% growth has been seen.